Free Trial

Medicus Pharma (MDCX) 10K Form and Latest SEC Filings 2026

Medicus Pharma logo
$0.28 -0.01 (-3.98%)
Closing price 04:00 PM Eastern
Extended Trading
$0.28 +0.00 (+1.09%)
As of 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Medicus Pharma SEC Filings & Recent Activity

Medicus Pharma (NASDAQ:MDCX) has submitted 232+ documents to the U.S. Securities and Exchange Commission (SEC) since 2023. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form SCHEDULE 13G/A submitted on May 5, 2026.

Form 4
Medicus Pharma Ltd. Reports Ownership Change on Apr. 1, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Medicus Pharma Files Current Report on Apr. 24, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
Medicus Pharma Files Annual Report on Apr. 29, 2026

The 10-K contains Medicus Pharma's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Medicus Pharma SEC Filing History

Browse Medicus Pharma's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/05/2026 9:54 AM
Medicus Pharma (1997296) Subject
Raju Ajay (2049841) Filed by
Form SCHEDULE 13G/A
05/04/2026 3:35 PM
Medicus Pharma (1997296) Filer
Form ARS
04/29/2026 4:21 PM
Medicus Pharma (1997296) Filer
Form 10-K/A
04/24/2026 4:27 PM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2026 4:10 PM
Medicus Pharma (1997296) Filer
Form 424B3
04/21/2026 5:01 AM
Medicus Pharma (1997296) Filer
Form PRE 14A
04/01/2026 6:14 PM
MAHAFFY PATRICK J (1266569) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:15 PM
May Sara R. (2048946) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:17 PM
Medicus Pharma (1997296) Issuer
Mehmud Faisal (2047946) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:18 PM
Medicus Pharma (1997296) Issuer
Raju Ajay (2049841) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:20 PM
Medicus Pharma (1997296) Issuer
Rodgers Cathy McMorris (2078262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:22 PM
Medicus Pharma (1997296) Issuer
Smith Andrew Alasdair (1309614) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:12 PM
Kaiser Larry (2048184) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:03 PM
Ashton William (1474553) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:05 PM
Bokhari Raza (1660525) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:07 PM
Bonner Carolyn F. (2047487) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:08 PM
Brennan Edward J. (2048104) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:09 PM
Ciaruffoli Robert J. (2048095) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 6:11 PM
FISHMAN BARRY (1889532) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2026 11:15 PM
Medicus Pharma (1997296) Filer
Form EFFECT
03/29/2026 11:15 PM
Medicus Pharma (1997296) Filer
Form EFFECT
03/29/2026 11:15 PM
Medicus Pharma (1997296) Filer
Form EFFECT
03/25/2026 4:05 PM
Medicus Pharma (1997296) Filer
Form POS AM
03/25/2026 4:09 PM
Medicus Pharma (1997296) Filer
Form POS AM
03/25/2026 4:13 PM
Medicus Pharma (1997296) Filer
Form POS AM
03/25/2026 3:49 PM
Medicus Pharma (1997296) Filer
Form 424B3
03/25/2026 3:51 PM
Medicus Pharma (1997296) Filer
Form 424B3
03/25/2026 3:51 PM
Medicus Pharma (1997296) Filer
Form 424B3
03/25/2026 3:52 PM
Medicus Pharma (1997296) Filer
Form 424B3
03/25/2026 3:08 PM
Medicus Pharma (1997296) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2026 3:49 PM
Medicus Pharma (1997296) Filer
Form 253G2
03/06/2026 3:52 PM
Medicus Pharma (1997296) Filer
Form 424B3
03/06/2026 3:40 PM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2026 11:15 PM
Medicus Pharma (1997296) Filer
Form EFFECT
01/30/2026 3:31 PM
Medicus Pharma (1997296) Filer
Form S-3
Registration statement under Securities Act of 1933  
01/05/2026 7:35 PM
Bokhari Raza (1660525) Filed by
Medicus Pharma (1997296) Subject
Form SCHEDULE 13G/A
01/02/2026 9:25 AM
Medicus Pharma (1997296) Filer
Form 424B5
01/01/2026 11:15 PM
Medicus Pharma (1997296) Filer
Form EFFECT
12/30/2025 8:58 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/30/2025 8:58 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/30/2025 9:01 AM
Medicus Pharma (1997296) Filer
Form 253G2
12/30/2025 9:02 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/30/2025 9:03 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/30/2025 9:06 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/30/2025 9:09 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/30/2025 8:26 AM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2025 8:50 PM
Medicus Pharma (1997296) Filer
Form S-3
Registration statement under Securities Act of 1933  
12/18/2025 3:06 PM
Ashton William (1474553) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:06 PM
Bokhari Raza (1660525) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:07 PM
Bonner Carolyn F. (2047487) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:07 PM
Brennan Edward J. (2048104) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:08 PM
Ciaruffoli Robert J. (2048095) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:08 PM
FISHMAN BARRY (1889532) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:08 PM
Kaiser Larry (2048184) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:08 PM
MAHAFFY PATRICK J (1266569) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:09 PM
May Sara R. (2048946) Reporting
Medicus Pharma (1997296) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:09 PM
Medicus Pharma (1997296) Issuer
Mehmud Faisal (2047946) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:09 PM
Medicus Pharma (1997296) Issuer
Raju Ajay (2049841) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:09 PM
Medicus Pharma (1997296) Issuer
Rodgers Cathy McMorris (2078262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:10 PM
Medicus Pharma (1997296) Issuer
Smith Andrew Alasdair (1309614) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 4:26 PM
Medicus Pharma (1997296) Filer
Form 253G2
12/08/2025 4:02 PM
Medicus Pharma (1997296) Filer
Form 424B3
12/08/2025 4:03 PM
Medicus Pharma (1997296) Filer
Form 424B3
12/08/2025 4:03 PM
Medicus Pharma (1997296) Filer
Form 424B3
12/08/2025 4:04 PM
Medicus Pharma (1997296) Filer
Form 424B3
12/08/2025 4:05 PM
Medicus Pharma (1997296) Filer
Form 424B3
12/08/2025 4:06 PM
Medicus Pharma (1997296) Filer
Form 424B3
12/08/2025 3:30 PM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2025 11:15 PM
Medicus Pharma (1997296) Filer
Form EFFECT
12/01/2025 7:39 AM
Medicus Pharma (1997296) Filer
Form 253G2
12/01/2025 7:18 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/01/2025 7:19 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/01/2025 7:21 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/01/2025 7:13 AM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2025 7:15 AM
Medicus Pharma (1997296) Filer
Form 424B3
12/01/2025 7:18 AM
Medicus Pharma (1997296) Filer
Form 424B3
11/19/2025 4:00 PM
Medicus Pharma (1997296) Filer
Form S-1
Registration statement under Securities Act of 1933  
11/16/2025 11:15 PM
Medicus Pharma (1997296) Filer
Form EFFECT
11/16/2025 11:15 PM
Medicus Pharma (1997296) Filer
Form EFFECT
11/14/2025 4:17 PM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2025 4:00 PM
Medicus Pharma (1997296) Filer
Form 253G2
10/17/2025 4:03 PM
Medicus Pharma (1997296) Filer
Form 424B3
10/17/2025 4:07 PM
Medicus Pharma (1997296) Filer
Form 424B3
10/17/2025 3:44 PM
Medicus Pharma (1997296) Filer
Form 424B3
10/17/2025 3:30 PM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2025 4:04 PM
Medicus Pharma (1997296) Filer
Form S-1
Registration statement under Securities Act of 1933  
09/29/2025 4:08 PM
Medicus Pharma (1997296) Filer
Form S-1
Registration statement under Securities Act of 1933  
09/18/2025 7:32 AM
Medicus Pharma (1997296) Filer
Form 253G2
09/18/2025 7:35 AM
Medicus Pharma (1997296) Filer
Form 424B3
09/18/2025 7:38 AM
Medicus Pharma (1997296) Filer
Form 424B3
09/18/2025 7:00 AM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2025 7:12 AM
Medicus Pharma (1997296) Filer
Form 424B3
09/15/2025 5:43 AM
Medicus Pharma (1997296) Filer
Form 424B3
09/15/2025 5:32 AM
Medicus Pharma (1997296) Filer
Form 424B3
09/15/2025 5:38 AM
Medicus Pharma (1997296) Filer
Form 253G2
09/15/2025 5:40 AM
Medicus Pharma (1997296) Filer
Form 424B3
09/12/2025 4:05 PM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2025 3:36 PM
MAHAFFY PATRICK J (1266569) Reporting
Medicus Pharma (1997296) Issuer
Form 3
Initial statement of beneficial ownership of securities  
09/02/2025 1:15 PM
Medicus Pharma (1997296) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2025 3:59 PM
Medicus Pharma (1997296) Filer
Form 424B3
(Data available from 1/1/2016 forward)

Medicus Pharma SEC Filings - Frequently Asked Questions

Medicus Pharma (MDCX) has submitted 232+ filings to the SEC since 2023. You can browse the complete history or filter by form type using the tools above.

Medicus Pharma's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form SCHEDULE 13G/A submitted on May 5, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:MDCX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners